Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry)

One‐Year Outcome of Small‐Vessel Disease Treated with Sirolimus‐Eluting Stents: A Subgroup Analysis of the e‐SELECT Registry

“…In terms of the potential for improving outcomes of PCI in SmVD, studies have shown that specific baseline clinical and angiographic characteristics are predictive of the different rates of MACE, including restenosis, seen for various lesion/patient subsets . Diabetes, for instance, exacerbates the negative impact on outcomes of smaller vessel size,,,, and insulin treatment was a multivariate predictor of in‐segment restenosis in the Taxus in Real‐life Usage Evaluation (TRUE) registry . In this study IDDM was identified as one of the multivariate predictors of 1‐year MACE.…”

“…From approximately one‐third to over one‐half of percutaneous coronary intervention (PCI) is targeted at significant disease in small coronary artery segments, defined as those with estimated reference vessel diameter (RVD) under a threshold ranging from 2.5 mm to 3 mm depending on the study –. PCI of small coronary artery segments, relative to that of larger caliber vessels, is significantly and directly associated with an increased risk of major adverse cardiovascular events (MACE), including restenosis and stent thrombosis (ST) –.…”

Predicting risk of complications following a drug eluting stent procedure: A SVM approach for imbalanced data

“…These were matched with the attributes considered in earlier works done on predictors for complications following PCI/DES procedures [21], [22], [23]. All the 165 variables that were considered, have been listed in Table 2.…”

Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter

“…So berichteten Elezi et al [113] nach Cypher TM -oder Taxus TM -Stentimplantation bei Gefäßdurchmessern zwischen 2,41 und 2,81 mm über eine ISRHäufigkeit von 13,3%, während in Gefä-ßen < 2,41 mm die Rezidivrate bei 19,5% lag. Weitere Registerdaten zeigen nach Implantation von Taxus TM -Stents und Gefäßdurchmessern < 2,25 mm ISR-Raten von bis zu knapp 30% [114].…”